Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Ibuprofen for Post-Surgical Dental Pain
NCT01216163Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in odontalgia (3 arms), sponsored by Pfizer. Primary endpoints: Time-weighted Sum of Pain Relief Rating With Pain Intensity Difference From 0 to 6 Hours and Time to Onset of Meaningful Relief. Started Oct 2010; status: completed.
02
Drugs
ibuprofen
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT01216163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216163.